HRMY vs IDYA Stock Comparison

HRMY currently leads IDYA in this stock comparison, with AIQ scores of 73 vs 54. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 19 points
HRMY
Healthcare
vs
IDYA
Healthcare
HRMY
Harmony Biosciences Holdings, Inc.
Leads
Price
$33.76
Day move
-0.12%
AIQ Score
73/100
Best edge
Value
Sector
Healthcare
IDYA
IDEAYA Biosciences, Inc.
Price
$31.83
Day move
+1.08%
AIQ Score
54/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between HRMY and IDYA?

HRMY leads the current stock comparison as Harmony Biosciences Holdings, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Harmony Biosciences Holdings, Inc. vs IDEAYA Biosciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

HRMY leads

HRMY leads by 19 AIQ points, primarily on Value and Quality.

Competitive: 2 of 6 evidence groups support HRMY, and its signal state is cleanly positive.

Evidence agreement: 2 of 6Comparison trend: Stable
HRMY

Harmony Biosciences Holdings, Inc.

Leads
AIQ Score
73/100
AIQ Edge Score
9/10
IDYA

IDEAYA Biosciences, Inc.

AIQ Score
54/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors HRMY over IDYA, 73 versus 54 as of Nov 15, 2026. HRMY's advantage is driven primarily by stronger value and quality. HRMY also shows the weaker technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor HRMY today, and the comparison is rated Competitive on stability: only 2 of 6 covered evidence groups agree. HRMY lead: Stable — the AIQ differential has held near 19 points over 30 sessions.

Compare Harmony Biosciences Holdings, Inc. and IDEAYA Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

HRMY
-15.9%
IDYA
+34.4%

Price return comparison

Growth of $10,000, price only

HRMY $8,413 · IDYA $13,442

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare HRMY and IDYA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

HRMY advantage
0
IDYA advantage
  • Value89 vs 39
    HRMY +50
  • Quality77 vs 51
    HRMY +26
  • Momentum66 vs 63
    Even
  • Risk Resilience63 vs 61
    Even

2 of 6 evidence groups favor HRMY. HRMY’s edge is concentrated in value and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

HRMY0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 3 active signals are unchanged.

IDYA0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)

HRMY's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — HRMY and IDYA both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HRMY

HRMY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

IDYA

IDYA on combined revenue and EPS growth.

Value

HRMY

HRMY on the peer-relative Value factor, by 50 points.

Momentum

Even

The two are level on Momentum.

Lower downside

HRMY

HRMY carries the lower 1-month annualized volatility.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureHRMYIDYANote
Implied upside to target+52.5%+53.2%Level
Target dispersion+35%+36.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1216Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 6 covered evidence groups favor HRMY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHRMY73 vs 54
FundamentalsEvenrevenue growth 2.9% vs 15.6%; TTM ROE 4.5% vs -11.5%; gross margin 74% vs 100%; operating margin 22.2% vs -12.7%
ValuationHRMYValue 89 vs 39
TechnicalsEvenPrice vs 50-day -12.6% vs -10.3%; vs 200-day -2.4% vs -6%
Risk ResilienceEvenRisk Resilience 63 vs 61
Analyst expectationsEvenTarget upside 52.5% vs 53.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of HRMY and IDYA and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 19 points. (supports the conclusion holding)
  • Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HRMY.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

HRMY lead: Stable — the AIQ differential has held near 19 points over 30 sessions.

May 27HRMY leads above the line · IDYA leads belowNov 13
Today
HRMY +19
73 vs 54
7 sessions ago
HRMY +22
76 vs 54
30 sessions ago
HRMY +17
80 vs 63
90 sessions ago
HRMY +9
74 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

HRMY

1 bullish / 0 bearish / 2 neutral

No signal that the other name lacks.

IDYA

4 bullish / 0 bearish / 2 neutral

Only IDYA

  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

Both carry 3 more signals that do not separate them: Golden Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

HRMYNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.12%, AIQ 0 points).

IDYANo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.08%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IDYA closes the Value gap — currently 50 points behind, the largest single contributor to HRMY's edge.
  2. 2IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish.
  3. 3HRMY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricHRMYIDYA
Revenue growth (YoY)2.9%15.6%
EPS growth (YoY)-36.2%0%
Gross margin74%100%
Operating margin22.2%-12.7%
Return on equity (TTM)4.5%-11.5%
Debt to equity0.140.03

Performance

Split across windows
MetricHRMYIDYA
1 week (5 sessions)2%1.9%
1 month (20 sessions)-11%-3.1%
3 months (63 sessions)-11.5%-12.9%
6 months (126 sessions)12.2%12.8%
Year to date-9.8%-7.9%
1 year (252 sessions)0.7%-0.4%

Technicals

Split
MetricHRMYIDYA
RSI (14)36.442.4
ADX (14)34.725.8
Price vs 50-day-12.6%-10.3%
Price vs 200-day-2.4%-6%
Volatility (1M, annualized)46.4%48.2%

Risk

Split
MetricHRMYIDYA
Beta0.630.94
Sharpe ratio0.070.14
Sortino ratio0.090.2
Max drawdown-34.5%-27.8%
Current drawdown-21.2%-25.1%
Annualized volatility40.6%44.9%
Value at risk (95%)-3.9%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, HRMY or IDYA?

On the Algovestiq AIQ Score, HRMY is the stronger of the two as of Nov 15, 2026, scoring 73 against IDYA's 54. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is HRMY or IDYA the better buy right now?

HRMY carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 2 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor HRMY over IDYA?

The composite weights Quality, Value, Momentum and Risk Resilience. HRMY leads Value by 50 points; HRMY leads Quality by 26 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, HRMY or IDYA?

Analyst price targets imply +52.5% upside for HRMY and +53.2% for IDYA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, HRMY or IDYA?

HRMY is the better-valued of the two on the peer-relative Value factor. HRMY on the peer-relative Value factor, by 50 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, HRMY or IDYA?

IDYA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, HRMY or IDYA?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, HRMY or IDYA?

HRMY is the more resilient of the two, so the other name carries the higher downside risk. HRMY carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is HRMY more profitable than IDYA?

The profitability evidence is mixed: gross margin 74% vs 100%; operating margin 22.2% vs -12.7%; ttm roe 4.5% vs -11.5%. HRMY leads on two measures and IDYA on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is HRMY's lead over IDYA getting stronger or weaker?

HRMY lead: Stable — the AIQ differential has held near 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the HRMY vs IDYA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IDYA closes the Value gap — currently 50 points behind, the largest single contributor to HRMY's edge; IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish; HRMY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about HRMY and IDYA?

HRMY: 1 bullish / 0 bearish / 2 neutral. IDYA: 4 bullish / 0 bearish / 2 neutral. The most decision-relevant rule on HRMY is Golden Cross Active (bullish, long horizon). On IDYA it is Golden Cross Active (bullish, long horizon).

Compare HRMY and IDYA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.